在下胃肠道非新生性炎症条件下,细胞粘素
Zhiyan Fu1, Eundong Park2, Hasan Basri Aydin2
1Department of Pathology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Annals of diagnostic pathology
|February 14, 2025
概括
胃肠道下部的非细胞性粘素可以发生在良性疾病中,如尾炎和尾炎,通常是由于转位. 认识到这一点可以防止不必要的调查和节约资源.
科学领域:
- 胃肠病学 胃肠病学
- 手术病理学手术病理学
- 在瘤学瘤学.
背景情况:
- 下胃肠道 (GI) 中的非细胞性粘素通常表明产生粘素的瘤,这促使进一步调查.
- 在良性疾病中,非细胞性粘素的临床意义尚不清楚.
研究的目的:
- 调查无细胞粘素在良性下部肠道疾病中的发生和临床意义.
- 为了区分无细胞粘素在良性条件下与瘤过程中的发现.
主要方法:
- 在良性条件下 (椎炎,尾炎,其他) 以非细胞性粘素进行下部肠道外科试验的回顾性审查.
- 与对照组进行比较:低度尾粘膜瘤 (LAMN) 和没有非细胞性粘膜的分泌体炎.
- 收集临床数据,组织学发现,并详细说明额外的工作.
主要成果:
- 在尾炎病例中,细胞粘素经常呈现出急性尾炎症状,与LAMN不同.
- 对于具有或没有非细胞性粘素的结肠膜膜炎,在临床或炎症参数方面没有发现显著差异.
- 在大多数"其他"良性疾病中,与非细胞性粘液一起,注意到了腹部手术或抽的病史.
结论:
- 在良性下胃肠道疾病中,无细胞粘素被认知不足,可能导致广泛的炼.
- 粘素通过分泌管或缺陷的转移可能解释了它在良性病例中的存在.
- 临床背景对于准确诊断至关重要,防止不必要的调查和优化资源利用.
相关概念视频
Mucosal Barrier of the Stomach
444
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
444
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
344
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
344
Gastritis-II: Pathophysiology
209
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
209
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
524
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
524
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
327
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
327
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
364
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
364


